Literature DB >> 10406452

Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis.

S D Kanters1, J D Banga, R P Stolk, A Algra.   

Abstract

Patients with diabetes mellitus are at increased risk of developing atherosclerotic disease. The extent of this additional risk and its determinants are not well known, but this information is needed for sample-size estimations in intervention studies. Therefore, a meta-analysis of epidemiologic studies on this subject was performed. Medline was searched from 1966 onwards, including the reference lists of all relevant publications. A total of 27 prospective follow-up studies in the English language that allowed calculation of the unadjusted incidence of one of the predefined outcome events were included. The influence of age, sex, type of diabetes, duration of diabetes, year of study, HbA1c, cholesterol level, blood pressure and smoking on these incidences was studied by means of univariate Poisson regression analysis. Overall total mortality was 2.9% per year (95% CI 2.8-3.0; 27 studies), and for death from all vascular causes was 1.4% per year (95% CI 1.3-1.4; 16 studies). Only two studies were found that reported on the incidence of the composite outcome 'event death from all vascular causes, non-fatal myocardial infarction, or non-fatal stroke'. In univariate analysis, age, year of study, total cholesterol and systolic blood pressure were positively related to total mortality and death from all vascular causes. After adjustment for age, or limiting the analyses to studies in patients with type 2 diabetes only (n = 11), these relationships remained statistically significant. In conclusion, the overall yearly total mortality in diabetes mellitus is 2.9% and for death from all vascular causes is 1.4%. There are few data on the incidence of composite cardiovascular outcome events.

Entities:  

Mesh:

Year:  1999        PMID: 10406452     DOI: 10.1177/1358836X9900400203

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  5 in total

Review 1.  Stress echocardiography for risk assessment of diabetic patients.

Authors:  L H B Baur; M Graal
Journal:  Neth Heart J       Date:  2004-10       Impact factor: 2.380

2.  Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state.

Authors:  A Willfort-Ehringer; R Ahmadi; A Gessl; M E Gschwandtner; A Haumer; W Lang; E Minar; S Zehetmayer; H Ehringer
Journal:  Diabetologia       Date:  2004-02-18       Impact factor: 10.122

3.  Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a.

Authors:  Fengyun Zhang; Kun Wang; Fei Gao; Yongli Xuan; Xiaohong Liu; Zhuoqi Zhang
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

4.  Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia.

Authors:  Jeanette Kuhl; Gun Jörneskog; Malin Wemminger; Mattias Bengtsson; Pia Lundman; Majid Kalani
Journal:  Cardiovasc Diabetol       Date:  2015-09-17       Impact factor: 9.951

5.  Metabolic effects of antihyperglycemic agents and mortality: meta-analysis of randomized controlled trials.

Authors:  Dimitris Varvaki Rados; Camila Viecceli; Lana Catani Pinto; Fernando Gerchman; Cristiane Bauermann Leitão; Jorge Luiz Gross
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.